Investigation of metabolic and circulatory parameters that predict effects of dapagliflozin, a sodium-glucose cotransporter 2 inhibitor, on blood glucose and body weight in a retrospective, multicenter study

o1892_all

WEKO3

lat lon distance

[[sub_check.contents]]

[[sub_radio.contents]]

Field does not validate

[[sub_attr.contents]]　

o1892_all.pdf

https://fukuoka-u.repo.nii.ac.jp/record/5284/files/o1892_all.pdf

application/pdf

ファイル	ライセンス
o1892_all.pdf (288.7 kB) sha256 f138ce2111cac306f34044ce5162a21d4da76b195e84604a4c0e27146817ea86

Version	Date Modified	Object File Name	File Size	File Hash Value	Contributor Name	Show/Hide

Downloads

Plays